140 related articles for article (PubMed ID: 3594830)
21. Excretion of endogenous digoxin-like immunoreactive factors in human urine is a function of urine flow rate.
Siegfried BA; Valdes R
Clin Chem; 1988 May; 34(5):960-4. PubMed ID: 3370798
[TBL] [Abstract][Full Text] [Related]
22. Detection of endogenous digitalis-like immunoreactive factors in human blood.
Lin MH; Liao CP; Lee JS; Chin YW; Hsu CC; Wei JS
Proc Natl Sci Counc Repub China B; 1998 Jul; 22(3):129-35. PubMed ID: 9779602
[TBL] [Abstract][Full Text] [Related]
23. Analytical performance of a monoclonal digoxin assay with increased specificity on the ACS:180.
Miller JJ; Straub RW; Valdes R
Ther Drug Monit; 1996 Feb; 18(1):65-72. PubMed ID: 8848824
[TBL] [Abstract][Full Text] [Related]
24. Multicenter study of Abbott AxSYM Digoxin II assay and comparison with 6 methods for susceptibility to digoxin-like immunoreactive factors.
Azzazy HM; Duh SH; Maturen A; Schaller E; Shaw L; Grimaldi R; Shock G; Christenson RH
Clin Chem; 1997 Sep; 43(9):1635-40. PubMed ID: 9299945
[TBL] [Abstract][Full Text] [Related]
25. Endogenous digoxin-like immunoreactive factor and digitalis-like factor associated with the hypertension of patients receiving multiple alkylating agents as part of autologous bone marrow transplantation.
Graves SW; Eder JP; Schryber SM; Sharma K; Brena A; Antman KH; Peters WP
Clin Sci (Lond); 1989 Nov; 77(5):501-7. PubMed ID: 2555106
[TBL] [Abstract][Full Text] [Related]
26. [False results of measuring digoxin levels in patients with renal failure. Comparison of the RIA--FPIA methods].
Jankowski A; Karwowski J; Marzec A; Kretowicz W; Nartowicz E
Kardiol Pol; 1990 Feb; 33(2):116-21. PubMed ID: 2277482
[TBL] [Abstract][Full Text] [Related]
27. Inaccuracies in digoxin measurement.
Cook JD; Koch TR; Cook MS; Knoblock EC
Clin Biochem; 1988 Dec; 21(6):353-7. PubMed ID: 3233747
[TBL] [Abstract][Full Text] [Related]
28. Interference with digoxin immunoassays.
Bottorff MB; Phelps SJ; Hoon TJ
Clin Pharm; 1987 Feb; 6(2):100-2. PubMed ID: 3665365
[No Abstract] [Full Text] [Related]
29. [High digoxin serum levels in an elderly patient for the endogenous digoxin-like immunoreactive substances. A case report].
Suppa M; Giancaspro G; Coppola A; Colzi M; Marini ME; Magnanelli E; Baldini E; Cavicchi F; Petroni C; Contu E; Boccardo C; Scarpellini MG
Clin Ter; 2011; 162(3):245-8. PubMed ID: 21717052
[TBL] [Abstract][Full Text] [Related]
30. Influence of assay methodologies and interferences on the interpretation of digoxin concentrations.
Fitzsimmons WE
Drug Intell Clin Pharm; 1986; 20(7-8):538-42. PubMed ID: 3755675
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of five immunoassays for the determination of digoxin in serum.
Sasieta M; Jimeno P
Eur J Clin Chem Clin Biochem; 1996 Nov; 34(11):935-40. PubMed ID: 8960471
[TBL] [Abstract][Full Text] [Related]
32. Endogenous digoxin-like immunoreactive factor (DLIF) serum concentrations are decreased in manic bipolar patients compared to normal controls.
Grider G; El-Mallakh RS; Huff MO; Buss TJ; Miller J; Valdes R
J Affect Disord; 1999 Aug; 54(3):261-7. PubMed ID: 10467969
[TBL] [Abstract][Full Text] [Related]
33. Effects on renal function and digoxin-like immunoreactivity produced by methimazole in low-renal mass hypertension.
Andrade JL; Haro JM; Sabio JM; Garcia del Rio C; Vargas F
Clin Exp Hypertens A; 1992; 14(6):1003-16. PubMed ID: 1424215
[TBL] [Abstract][Full Text] [Related]
34. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.
Morris RG; Frewin DB; Saccoia NC; Goldsworthy WL; Jeffries WS; McPhee AJ
Eur J Clin Pharmacol; 1990; 39(4):359-63. PubMed ID: 2076718
[TBL] [Abstract][Full Text] [Related]
35. Endogenous digoxin-like immunoreactive factor is elevated in advanced chronic respiratory failure.
Varsano S; Shilo L; Bruderman I; Dolev S; Shenkman L
Chest; 1992 Jan; 101(1):146-9. PubMed ID: 1309496
[TBL] [Abstract][Full Text] [Related]
36. Digoxin-like immunoreactive factor(s) in human gonadotropin stimulated follicular fluid.
Jakobi P; Krivoy N; Eibschitz I; Ziskind G; Barzilai D; Paldi E
J Clin Endocrinol Metab; 1989 Jul; 69(1):209-11. PubMed ID: 2499591
[TBL] [Abstract][Full Text] [Related]
37. Interference from digitoxin-like immunoreactive factors reduced in a new monoclonal chemiluminescent digitoxin assay.
Datta P; Dasgupta A
Ther Drug Monit; 1998 Dec; 20(6):663-8. PubMed ID: 9853984
[TBL] [Abstract][Full Text] [Related]
38. Serum digoxin-like immunoreactive factor in children and its relation to sodium metabolism.
Garbagnati E
Acta Paediatr; 1998 May; 87(5):500-4. PubMed ID: 9641729
[TBL] [Abstract][Full Text] [Related]
39. Endogenous digoxin-like factor raises blood pressure and protects against digitalis toxicity.
Shilo L; Pomeranz A; Rathaus M; Bernheim J; Shenkman L
Life Sci; 1989; 44(24):1867-70. PubMed ID: 2739503
[TBL] [Abstract][Full Text] [Related]
40. Endogenous digoxin-like immunoreactivity in blood is increased during prolonged strenuous exercise.
Valdes R; Hagberg JM; Vaughan TE; Lau BW; Seals DR; Ehsani AA
Life Sci; 1988; 42(1):103-10. PubMed ID: 3336270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
